With over a decade of leadership experience in Computerized Systems Validation and quality assurance, I have become passionate about the ways AI can impact not only the pharmaceutical and biotech industries but also the most vulnerable individuals – patients. I explore the ways of implementing the complex and dynamic nature of AI laws and regulatory guidelines into company-specific processes and procedures.